Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
6.79
+0.33 (5.03%)
Nov 5, 2025, 10:41 AM EST - Market open
Myriad Genetics Employees
Myriad Genetics had 2,700 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2,700
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$305,667
Profits / Employee
-$148,333
Market Cap
632.46M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,700 | 0 | - |
| Dec 31, 2023 | 2,700 | 100 | 3.85% |
| Dec 31, 2022 | 2,600 | 200 | 8.33% |
| Dec 31, 2021 | 2,400 | -300 | -11.11% |
| Dec 31, 2020 | 2,700 | 0 | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MYGN News
- 1 day ago - Myriad Genetics, Inc. (MYGN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution - GlobeNewsWire
- 5 days ago - New Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner - GlobeNewsWire
- 8 days ago - Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025 - GlobeNewsWire
- 22 days ago - Myriad Genetics Adds F8, FXN Genes to Foresight Universal Plus Panel - GlobeNewsWire
- 27 days ago - Breast Cancer Awareness Month: Patient and Clinician Share Insights on how to tackle the fear of cancer screenings on YourUpdateTV - GlobeNewsWire
- 6 weeks ago - Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy - PRNewsWire
- 6 weeks ago - Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy - GlobeNewsWire